B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses

Author:

Lin Ke1,Zhou Yawen2,Ai Jingwen1,Wang Yan A.3,Zhang Senxin4,Qiu Chao15,Lian Chaoyang6,Gao Bo6,Liu Tingting2,Wang Hongyu1,Zhang Haocheng1,Zhang Yi1,Fu Zhangfan1,Li Dan3,Jiang Ning7,Guo Jingxin1,Wu Jing1,Wang Yan O.8,Song Shusen3,Li Qiang3,Yin Yanan9,Xia Jia10,Xu Yingjie9,Yeap Leng-Siew6,Zheng Xiaoqi4,Gu Ye3,Liu Hongyan3,Zhang Wenhong15811,Meng Fei-Long2

Affiliation:

1. Department of Infectious Disease of Huashan Hospital, National Medical Center for Infectious Diseases and Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Fudan University, Shanghai, People’s Republic of China

2. State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of China

3. CHESS-COVID-19 Group; Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China

4. Department of Mathematics, Shanghai Normal University, Shanghai, People’s Republic of China

5. Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China

6. Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

7. State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, People's Republic of China

8. Liaoning Emergency Treatment and Innovation Center of Public Health Emergencies, The Sixth People's Hospital of Shenyang, Shenyang, People's Republic of China

9. Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

10. Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

11. National Clinical Research Centre for Aging & Medicine, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Shanghai Science and Technology Committee

Chinese Academy of Sciences

Shanghai Municipal Health Commission

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3